Medios AG | WebDisclosure

Basculer en Français

9478	Companies
185484	Keywords
117839	Articles
99329	Press releases

Home
Companies
Medios AG

PRESS RELEASE

published on 08/05/2024 at 10:32, 1 year 4 months ago

Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President
Medios AG strengthens activities in Advanced Therapies field, appoints Dr. Andreas Schmiede as Vice President. Focus on personalized medicine innovations and patient access to cutting-edge therapies

Medios AG Advanced Therapies Personalized Medicine Dr. Andreas Schmiede Pharmaceutical Innovations
BRIEF

published on 07/01/2024 at 09:37, 1 year 5 months ago

« Hauptstadtkongress 2024 » : Medios organise un symposium sur la « sécurité d'approvisionnement »

Medios AG Pharmacie Spécialisée Congrès De La Hauptstadt 2024 Système De Soins De Santé Sécurité D'approvisionnement
BRIEF

published on 07/01/2024 at 09:37, 1 year 5 months ago

“Hauptstadtkongress 2024”: Medios Hosts Symposium on 'Security of Supply'

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
PRESS RELEASE

published on 07/01/2024 at 09:32, 1 year 5 months ago

“Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply”
Medios AG participated in 'Hauptstadtkongress 2024', focusing on 'Security of supply'. Experts discussed challenges in patient care and the importance of cooperation in Specialty Pharma sector

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
BRIEF

published on 06/20/2024 at 10:07, 1 year 5 months ago

Transfert réussi des actions Medios AG à Luxempart SA

Investissement Medios AG Vente D'actions Pharmacie Spécialisée Luxempart SA
BRIEF

published on 06/20/2024 at 10:07, 1 year 5 months ago

Successful Transfer of Medios AG Shares to Luxempart S.A.

Investment Medios AG Share Sale Specialty Pharma Luxempart S.A.
PRESS RELEASE

published on 06/20/2024 at 10:02, 1 year 5 months ago

Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
Medios AG founder Manfred Schneider sells 14.9% of shares to Luxempart S.A., a Luxembourg investment company, marking a turning point in Medios' growth strategy

Investment Medios AG Specialty Pharma Luxempart S.A. Manfred Schneider
BRIEF

published on 06/07/2024 at 10:33, 1 year 5 months ago

Hauck & Aufhäuser lance la couverture de Medios AG avec une recommandation d'achat et un objectif de prix de 23,00 €

Medios AG Recommandation D'achat Pharmacie Spécialisée Hauck & Aufhäuser Objectif De Prix 23,00 €
BRIEF

published on 06/07/2024 at 10:33, 1 year 5 months ago

Hauck & Aufhäuser Initiates Coverage of Medios AG with Buy Recommendation and €23.00 Price Target

Buy Recommendation Medios AG Specialty Pharma Hauck & Aufhäuser Price Target €23.00
PRESS RELEASE

published on 06/07/2024 at 10:28, 1 year 5 months ago

Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
Hauck & Aufhäuser initiates coverage of Medios AG with buy recommendation and €23.00 price target, a 55% upside potential from Xetra closing price on June 5, 2024. Medios AG, a leading Specialty Pharma provider in Europe, aims at expanding innovative therapies

Buy Recommendation Medios AG Price Target Specialty Pharma Hauck & Aufhäuser

Accesswire

Published on 12/05/2025 at 15:35, 9 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 19 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 44 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 44 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 44 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:38, 5 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 12/05/2025 at 15:36, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Published on 12/05/2025 at 15:35, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/05/2025 at 15:33, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/05/2025 at 15:32, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc

Les Echos

Published on 12/05/2025 at 15:10, 33 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 33 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 45 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 59 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 59 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE